Featured Jobs
|
PPS Pension Services
|
|
Relationship Manager - Defined Contributions Daybright Financial
|
|
MAP Retirement
|
|
Frank Pension Consultants, Ltd.
|
|
Retirement Plan Onboarding Specialist Compass
|
|
DWC - The 401(k) Experts
|
|
DWC - The 401(k) Experts
|
|
Defined Contribution Account Manager Nova 401(k) Associates
|
Free Newsletters
“BenefitsLink continues to be the most valuable resource we have at the firm.”
-- An attorney subscriber
|
|
|
The Impact of Price Regulation on the Launch Delay of New Drugs - Evidence from 25 Major Markets
Patricia M. Danzon, Y. Richard Wang, Liang Wang via National Bureau of Economic Research [NBER] 
July 29, 2003 Working paper. Excerpt: We use a Cox proportional hazard model to analyze the launch experience in 25 major markets of 85 new chemical entities (NCEs) launched in the UK or US between 1994 and 1998.... Our results suggest that countries with lower expected prices or smaller expected market size experience longer delays in new drug access, controlling for per capita income and other country and firm characteristics. MORE >> |
| Please click here to report this link if it is broken (for example, if you see a "404 File Not Found" error message after you click on the linked news item's title). |
| An important word about authorship: BenefitsLink® created this link to the news item, but we are not the news item's author (unless expressly shown above). |